InMed Pharmaceuticals (INM) EBITDA Margin (2021 - 2025)
InMed Pharmaceuticals (INM) recorded EBITDA Margin of -249.87% in fiscal Q2 2026 (quarter ended Dec 31, 2025), down 51.90 percentage points from -197.97% a year earlier and down 92.08 percentage points from the prior quarter.
InMed Pharmaceuticals (INM) EBITDA Margin (2021 - 2025) Analysis & Trends
On a TTM basis, InMed Pharmaceuticals' EBITDA Margin came in at -153.32% as of Dec 31, 2025, up 5.00 percentage points year-over-year; for FY2025 (ended Jun 30, 2025), it was -132.63%, up 40.87 percentage points from FY2024.
- Annual EBITDA Margin has increased for three straight fiscal years, with a three-year change of +1435.04 percentage points (FY2022 to FY2025).
- Across earlier fiscal years, EBITDA Margin came in at -173.49% in FY2024 (+25.38 pp), -198.88% in FY2023 (+1368.79 pp) and -1567.67% in FY2022.
- The fiscal Q2 2026 figure is the lowest quarterly EBITDA Margin since fiscal Q1 2024.
- On a year-over-year basis, EBITDA Margin rose in four of the last eight quarters, with an average year-over-year change of -1.15 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 1237.44 percentage points in fiscal Q4 2023, against a drop of 135.60 percentage points in fiscal Q4 2024 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at -157.79% (Q1 2026), -94.80% (Q4 2025) and -147.09% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 217.60 Bn | 200.72 Bn | 4.43 Bn | 37.86% |
| 2 | Corning | 130.50 Bn | 123.63 Bn | 1.63 Bn | 24.17% |
| 3 | Sherwin Williams | 80.80 Bn | 79.84 Bn | 3.34 Bn | 20.93% |
| 4 | Air Products & Chemicals | 62.07 Bn | 59.97 Bn | 1.04 Bn | -54.15% |
| 5 | Corteva | 51.85 Bn | 40.65 Bn | 3.66 Bn | 37.61% |
| 6 | LyondellBasell Industries | 37.65 Bn | 27.27 Bn | 2.04 Bn | 20.59% |
| 7 | Nutrien | 34.70 Bn | 31.57 Bn | 3.25 Bn | 34.09% |
| 8 | Qnity Electronics | 26.13 Bn | 23.56 Bn | 666.00 Mn | 32.54% |
| 9 | Ati | 24.61 Bn | 22.75 Bn | 309.80 Mn | 20.93% |
| 10 | InMed Pharmaceuticals | 5.66 Mn | 3.46 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -249.87% |
| Sep 30, 2025 | -157.79% |
| Jun 30, 2025 | -94.80% |
| Mar 31, 2025 | -147.09% |
| Dec 31, 2024 | -197.97% |
| Sep 30, 2024 | -132.87% |
| Jun 30, 2024 | -154.27% |
| Mar 31, 2024 | -152.61% |
| Dec 31, 2023 | -128.18% |
| Sep 30, 2023 | -290.29% |
| Jun 30, 2023 | -18.68% |
| Mar 31, 2023 | -203.23% |
| Dec 31, 2022 | -460.82% |
| Sep 30, 2022 | -1,099.46% |
| Jun 30, 2022 | -1,256.12% |
| Mar 31, 2022 | -1,126.12% |
| Dec 31, 2021 | -1,607.86% |
InMed Pharmaceuticals EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=INM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "INM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=INM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();